In a landmark decision, the U.S. Department of Agriculture (USDA) has granted approval to lab-grown meat producers UPSIDE Foods and GOOD Meat to commercially sell their chicken products. This move marks the first time that cultivated meat, also known as synthetic or lab-grown meat, will be available to the public. However, the decision has raised concerns due to the use of immortalized cell lines, with claims of a potential link to cancer.
The approval from the USDA follows a "no questions" response issued by the U.S. Food and Drug Administration (FDA) to GOOD Meat earlier this year, deeming their lab-grown chicken product safe for consumption.
The debate around lab-grown meat took a controversial turn with claims that the products funded by Bill Gates, a prominent advocate for synthetic meat and globalist elites, may cause "turbo cancers" in humans. The National Pulse highlighted a Bloomberg story exploring Gates' involvement in the lab-grown meat industry and shed light on the use of immortalized cell lines by his companies.
Unlike normal meat cells, which have a limited lifespan, immortalized cell lines have the ability to continuously divide and replicate. This characteristic, while advantageous for the mass production of lab-grown meat, has raised concerns due to their potential pre-cancerous or cancerous nature. Immortalized cell lines are commonly used in medical research, but their consumption in food products has sparked apprehension among consumers.
Critics argue that the perpetual replication of these cell lines bears resemblance to cancerous growth, leading to ethical and health-related concerns. Despite industry experts expressing confidence in the safety of consuming lab-grown meat, the thought of ingesting products made from immortalized cell lines may deter some individuals.
The debate surrounding lab-grown meat is far from settled, with ongoing discussions about its environmental impact, nutritional value, and now the potential risks associated with immortalized cell lines. As the market for synthetic meat expands and regulatory agencies grapple with assessing its safety, a thorough examination of the scientific evidence and transparency in the approval process are crucial.
While the USDA's approval paves the way for lab-grown meat to enter the market, the concerns raised regarding immortalized cell lines underscore the need for further research and transparency. Striking a balance between innovation, food security, and consumer safety will be paramount as synthetic meat becomes more accessible to the public.